Dr. Lindsay A. Zilliox, MD

Dr. Zilliox practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Zilliox's NPI, 1457486581, was assigned on February 22, 2007. Dr. Zilliox graduated from Ohio State University College of Medicine in 2004. Dr. Zilliox holds Maryland license D68114.

Dr. Zilliox's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Zilliox's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Neurology Associates, P.A.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zilliox practices. Vendor and product names are available with a free account.

Neurology is Dr. Zilliox's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Zilliox is licensed in Maryland.

CMS data shows 276 Medicare services from Dr. Zilliox across 11 procedure codes in 2024, for 208 Medicare patients. Medicare paid $22,586 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 208 Medicare patients who saw Dr. Zilliox in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zilliox's median patient age at 62, with 55% women.

In 2024, Dr. Zilliox wrote 289 Medicare Part D claims for 46 patients. 61% of them were for generic drugs. CMS names the drug for 184 of them, across 9 drugs with 11 or more claims each, at $529,043 in total drug cost. In 2023, CMS named 251 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zilliox for performance year 2024, reported as part of a group. Dr. Zilliox accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Zilliox, published from 2015 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Diabetic Neuropathies and Diabetes Mellitus, Type 2. Dr. Zilliox's most frequent co-authors are Senda Ajroud-Driss, MD, Gustavo Jose Alameda, MD and Jinsy Andrews, MD.

Dmand AI links Dr. Zilliox to 2 clinical trials. Conditions studied include Diabetes Mellitus, Metabolic Syndrome and Glucose Metabolism Disorders.

CMS Open Payments shows 6 general payments to Dr. Zilliox from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. MDD US Operations, LLC paid the most, $121.

Dr. Zilliox graduated from Ohio State University College of Medicine in 2004.